Framing depression as a functional signal, not a disease: Rationale and initial randomized controlled trial
Hans S Schroder1, Andrew Devendorf2, Brian J Zikmund-Fisher3
1Department of Psychiatry, University of Michigan Medical School, United States.
Social Science & Medicine (1982)
|June 10, 2023
Summary
Framing depression as an adaptive signal, rather than a disease, reduced self-stigma and promoted more adaptive beliefs. This alternative messaging may benefit individuals with depression histories.
Area of Science:
- Psychiatry
- Psychology
- Evolutionary Psychology
Background:
- Depression is commonly viewed as a disease, which can increase stigma.
- Alternative frameworks are needed to mitigate negative consequences of popular depression messaging.
Purpose of the Study:
- To investigate the impact of framing depression as an adaptive signal versus a disease.
- To assess effects on self-stigma, offset efficacy, and beliefs about depression.
Main Methods:
- Online randomized-controlled study with 877 participants reporting depression histories.
- Participants viewed videos explaining depression as a "disease" (BPS condition) or an "adaptive signal" (Signal condition).
- Measured self-stigma, offset efficacy, and depression beliefs.
Main Results:
- The "Signal" condition significantly reduced self-stigma and increased adaptive beliefs about depression.
- Offset efficacy was greater in the "Signal" condition.
- Effects were more pronounced in females, who also showed a greater growth mindset.
Conclusions:
- Framing depression as an adaptive signal offers potential benefits over the disease model.
- This messaging strategy may reduce stigma and foster more adaptive perspectives.
- Further research into alternative depression framings is warranted.
Related Concept Videos
Depression: Overview
288
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
288
Depressive Disorders: Etiology
144
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
144
Depressive Disorders: MDD and Dysthymia
177
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
177
Cognitive Therapy
183
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
183
Antidepressant Drugs: MAOIs and Other Agents
280
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
280
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K


